COSMO Pharmaceuticals SAEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 63.6 CHF | 126,762 CHF | 52,311 CHF |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - CHF | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 17.190.494 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name COSMO Pharmaceuticals SA
Mitarbeiter 324
Handelsplatz SW
Ticker Symbol COPN
IPO Datum -
Adresse Riverside 2, Dublin, Ireland, D02 KV60
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Alessandro E. Della Cha LL.M | Non Executive Chairman |
| 2 | Mr. Giovanni Di Napoli | CEO & Director |
| 3 | Mr. Mauro Severino Ajani | Founder & Non-Executive Director |
| 4 | Mr. Niall Donnelly | Executive VP of Corporate Governance, Chief Sustainability Officer & Executive Director |
| 5 | Ms. Svetlana Sigalova | Chief Financial Officer |
| 6 | Mr. Davide Malavasi | Qualified Person & Technical Director |
| 7 | Mr. Luigi Longo | Chief Scientific Officer |
| 8 | Mr. Federico Sommariva | Chief Legal Counsel |
| 9 | Ms. Silvia Miliani | Chief HR Officer |
| 10 | Mr. Ngo Dinh Nhan | President of Cosmo Intelligent Medical Devices |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.